New-user revenue from Google Ads grew 260% for Muditam Ayurveda, with Branded Search returning 26.84x ROAS — the highest-efficiency segment in the account.
Muditam Ayurveda is a Delhi-based D2C Ayurvedic wellness brand selling doctor-formulated supplements for diabetes, liver, and metabolic-health customers across India, with 80,000+ customers and 8,000+ verified reviews.
CGM's mandate on Google Ads was to convert real search intent — people actively searching for a named health condition, not a generic wellness term — into revenue, while keeping Branded Search efficient and testing Non-Branded and Demand Gen honestly.
Over the reporting window, Google Ads became one of Muditam's most efficient paid acquisition channels — and the account data shows exactly which segments earned that efficiency and which didn't.
Session, new-user, and revenue figures are from GA4, comparing 19 May–16 Aug 2026 against 18 Feb–18 May 2026 on a 120-day attribution basis. ROAS and campaign-type figures on this page come from Google Ads' own platform reporting for 2 Apr–11 Jun 2026 — a different, non-blended window — shown separately rather than combined.
19 May–16 Aug 2026 vs 18 Feb–18 May 2026 · GA4 Paid Search + Google Ads Platform Report
₹11.3L in Google Ads spend converted into ₹94.0L in conversion value over the platform-reported window — an 8.32× blended return.
Google Ads platform reporting, 2 Apr–11 Jun 2026:
Branded Search carries the account, as expected — but Non-Branded PMax still returned a real, positive 2.82× on cold intent. Demand Gen underperformed at 0.41×, which is shown here rather than hidden inside a flattering blended number.
Demand Gen spent ₹6,623 for a 0.41× return — a real miss. It was flagged and reallocated toward Branded Search and Non-Branded PMax, the segments actually converting.
Muditam's storewide Shopify order data (all channels, Jan–May 2026) — shown to confirm paid-search-driven demand landed on a store that was already scaling, not propping up a flat baseline.
| Month | Orders | Revenue | AOV |
|---|---|---|---|
| Jan 2026 | 5,576 | ₹95.83L | ₹1,888 |
| Feb 2026 | 4,818 | ₹79.76L | ₹1,849 |
| Mar 2026 | 7,524 | ₹1.16Cr | ₹1,656 |
| Apr 2026 | 8,542 | ₹1.24Cr | ₹1,647 |
| May 2026 | 6,791 | ₹1.08Cr | ₹1,803 |
Orders grew 53% from January to April before a seasonal dip in May — the kind of storewide trend that gives paid-search revenue growth real context, not an isolated number.
The through-line: target the named condition someone is actively searching for, and report every segment's true number.
Roughly ₹59 cost per conversion — the account's clear efficiency anchor, and still worth optimizing rather than treating as automatic.
Search themes like "karela jamun juice for blood sugar" and "ayurvedic liver detox supplement buy online" — people mid-decision, not just browsing.
₹6,623 spend at a real loss. Reported honestly here, then budget moved to what was working.
Targeting built around diabetes, fatty liver, thyroid, and bone density — specific enough to match real purchase intent.
What running this account proved about CGM's approach to paid search.
Demand Gen's 0.41× is shown alongside Branded Search's 26.84×, not hidden inside one flattering average.
We still optimize it — 26.84× vs. a lazier branded campaign's typical return proves the difference active management makes.
Targeting people searching a specific health condition, not a generic wellness keyword — that's what converts strangers.
Paid Search worked alongside Paid Social and SEO in the same account strategy, not as a siloed report.
GA4 and Google Ads platform reporting run on different windows here, and we say so instead of blending them.
Every stat in this case study traces back to GA4 or the Google Ads platform report.
If your Google Ads account looks profitable on paper but you're not sure which campaigns are actually earning that number, this is what a true, unblended breakdown looks like. Let's run yours.
